The team said the sustained response to parvovirus B19, traditionally not thought to be a true persistent infection, indicates that the virus likely remains in the patient's body long after symptoms have cleared up.
The findings, reported in the open access journal PLoS Medicine, give a better understanding of the body's T cell response and have important implications for vaccine development and treatment of this viral infection.
Human parvovirus B19 can cause a wide range of conditions depending on the patient's immunologic and hematologic status. In people with, for example, sickle cell anemia, infection can cause severe aplastic anemia, where the bone marrow stops making blood completely for a time. In a normal person, parvovirus B19 infection is often asymptomatic but can result in long-term arthritis. In pregnant women, it can cause intrauterine fetal death.
The team of researchers from the Karolinska Institute, Stockholm, Sweden, and University of Oxford, Oxford, U.K., said that traditionally, clearance of acute infection has been associated with the lifelong emergence of antiviral IgG. But there has been increasing evidence for an important role for cellular immune responses, which suggests there might be more to the way the body deals with this virus.
The team studied two groups of people: 11 who had been recently infected and five who had the virus many years ago. The CD8+ T cell responses "increased in magnitude over the first year post infection despite resolution of clinical symptoms and control of viraemia," say the authors. However, patients tested many years after infection had lower frequencies of B19 specific T cells
The likely explanation for the body's immune response "is through low level antigen exposure," suggest the authors, and they conclude that these findings should be considered during vaccine development.
Citation: Isa A, Kasprowicz V, Norbeck O, Loughry A, Jeffery K, et al (2005) Prolonged activation of virusspecific CD8+ T cells after acute B19 infection. PLoS Med 2(12): e343.
CONTACT:
Adiba Isa
Karolinska Institute
Karolinska University Hospital, Solna
Stockholm, Sweden 17176
Tel: +46-8-517-7674
Fax: +46-8-337-394
adiba.isa@cmm.ki.se
PLEASE MENTION THE OPEN-ACCESS JOURNAL PLoS MEDICINE (www.plosmedicine.org) AS THE SOURCE FOR THESE ARTICLES AND PROVIDE A LINK TO THE FREELY-AVAILABLE TEXT. THANK YOU.
All works published in PLoS Medicine are open access. Everything is immediately available--to read, download, redistribute, include in databases, and otherwise use-- without cost to anyone, anywhere, subject only to the condition that the original authorship is properly attributed. Copyright is retained by the authors. The Public Library of Science uses the Creative Commons Attribution License.
Journal
PLoS Medicine